News By Tag
* Clinical Trials
* Data Management
* More Tags...
News By Location
CROS NT Announces ePharma Day Series 2012
CROS NT and ARITHMOS are sponsoring the ePharma Day series again in 2012. Only this year, the series has grown to include two new countries - Russia and the UK.
The theme of the ePharma Day series 2012 is “Traceability in Clinical Trials: from Study Design to Submission”.
The ePharma Day series began in 2009 with a one-day conference in Milan, Italy hosted by CROS NT and Easy-b. In 2010, German ePharma Day was added as CROS NT expanded with an office in Augsburg. Last year, the inaugural Spanish ePharma Day was held in Barcelona, Spain. The goal of the ePharma Day series is to promote relevant and timely topics in the pharmaceutical and biotech industry on a national level by inviting local experts to speak. The ePharma Day series are dual language events: the local language and English.
Due to the growing popularity of the ePharma Day series, two events have been added for 2012. The United Kingdom was a logical choice as CROS NT has expanded operations there this month and has a new Vice President, Andrew MacGarvey. The UK is also a hub for many large pharma companies and CROs.
Russia is an increasingly important market in clinical trials. The Russian market is at the center of the Eastern European growth spurt. Russia is part of the BRICM (Brazil, Russia, India, China, Mexico) emerging markets and the its pharmaceutical market generated $1 billion in 2009 with a growth rate of 14,5 percent.
The schedule for the ePharma Day Series is as follows:
19 APRIL: ITALIAN ePHARMA DAY in Milan, Italy
26 APRIL: GERMAN ePHARMA DAY in Frankfurt, Germany
19 JULY: RUSSIA ePHARMA DAY in Moscow, Russia
(TBD) SEPTEMBRE: UK ePHARMA DAY in London, UK
25 OCTOBER: Spanish ePharma Day in Madrid, Spain
For more information, visit the Easy-b website at http://www.epharmaday.org/
# # #
CROS NT is a global CRO specializing in statistical analysis, data management, eCRF, ePRO and Life Science Application Hosting Services. Founded in 1992, CROS NT has completed over 800 studies in a wide range of therapeutic areas for clinical and observational studies with expertise in oncology, respiratory and dermatology. CROS NT relies on leading technologies, proven processes and employs experts to deliver on every project’s requirements with a group of highly qualified project managers and biostatisticians.
Page Updated Last on: Feb 03, 2012